The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tritace 10 mg Tablets

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/084/008

Main Information

Trade NameTritace 10 mg Tablets
Active SubstancesRamipril
Dosage FormTablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/084/008

Group Information

ATC CodeC09AA ACE inhibitors, plain
C09AA05 ramipril


License statusAuthorised
Licence Issued18/11/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListRamipril 10mg Capsules/Tablets
Interchangeable List CodeIC0016-002-008
Interchangeable List DocumentPDF of Interchangeable List
« Back